Profil estimare risc cancer ovarian (HE4, CA 125, scor ROMA)
Overexpression of Bmi-1 has been reported in various human cancers and proved to be associated with poor ovarian cancer markers. Disscusion: Bmi-1 is expressed by various tumors and therefore may contribute to malignant transformation. Bmi-1 not only can lead mammary epithelial cells to senescence and immortalization, but also plays a key role in breast cancer. A significant correlation was observed between Bmi-1 expression and axillary lymph node metastases in lymph-ductal breast cancer.
Bmi-1 is expressed in cervical cancer and correlated with a poorer prognosis, suggesting that this protein participates in the development and progress of cervical cancer.
De ce se efectuează un test CA125?
Regarding ovarian cancer, the results of several immunohistochemical studies revealed overexpression of Bmi-1, especially in poorly differentiated ovarian carcinoma. There is a strong correlation between histological grade, clinical stage and its expression. Conclusions: Human genes of polycomb group correlated with various hematological and epithelial cancers identify new mechanisms of malignant transformation and pave the way for developing new cancer treatments and identify new diagnostic markers.
Bmi-1 and its expression in tissues taken from patients with cervical, breast and ovarian cancer could be a marker for diagnosis and prognosis, and not least a potential target of antitumor therapy. Sauvageau M, Sauvageau G. PLoS Biol,6 papilloma invertito naso sinusale : e Posterior transformation, neurological, abnormalities, and severe hematopoietic defects in mice with a targeted deletion of the bmi-1 proto-oncogene.
Genes Dev ; 8: — Bmi-1 is essential for the tumorigenicity of neuroblastoma cells. Am J Pathol ; 5.
Mihuțiu S. Corelații anatomo-clinice cu prognosticul în cancerul ovarian epitelial. Teza de doctorat, Facultatea de Medicina, Oradea Armstrong DK.
Te-ar mai putea interesa şi …
Relapsed ovarian cancer: ovarian cancer markers and management strategies for a chronic disease. Oncologist, ; 7 Suppl 5 : 20— Biochemical mechanisms of cisplatin cytotoxicity.
Anticancer Agents Med Chem ; 7: 3— Intensive expression of Bmi-1 is ovarian cancer markers new independent predictor of poor outcome in patients with ovarian carcinoma. BMC ; Global cancer statistics. J Clin. Relation of tumor size, lymph node status, and survival in 24, breast cancer cases. Cancer ; 63 1 : — Bmi-1promotes invasion and metastasis, and its elevated expression is correlated with an advanced stage of breast cancer.
Serum tumor markers for screening and early diagnosis of ovarian cancer
Mol Cancer ; 10 1 : Expression of BMI-1 and Mel in breast tissue-a diagnostic marker in patients with breast cancer. BMC Cancer; Bmi-1 mRNA as a possible prognostic factor for advanced breast cancer patients. Breast Cancer Res. The role of neoadjuvant chemotherapy and surgery in cervical cancer Int J Gynecol Cancer ; 20 11 Suppl 2 : S Neoadjuvant chemotherapy locally advanced cancer reduces surgical risks and lymph-vascular space involvement.
Chin J Cancer.
CA 125 markeri tumorali
The long-term efficacy of neoadjuvant chemotherapy followed by radical hysterectomy compared with radical surgery alone or concurrent chemoradiotherapy on locally ovarian cancer markers cervical cancer.
Int J Gynecol Cancer. Overexpression of Bmi-1 in uterine cervical cancer: correlation with clinicopathology and prognosis. Overexpression of polycomb protein BMI-1 in human specimens of breast, ovarian, endometrial and cervical cancer. Anticancer Res.